These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12022026)

  • 1. Massive vascular endothelium growth factor (VEGF) expression in Eales' disease.
    Perentes Y; Chan CC; Bovey E; Uffer S; Herbort CP
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):311-4. PubMed ID: 12022026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor upregulation in human central retinal vein occlusion.
    Pe'er J; Folberg R; Itin A; Gnessin H; Hemo I; Keshet E
    Ophthalmology; 1998 Mar; 105(3):412-6. PubMed ID: 9499769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-ocular expression of vascular endothelial growth factor (VEGF) and pigment epithelial-derived factor (PEDF) in a case of Eales' disease by immunohistochemical analysis: a case report.
    Verma A; Biswas J; Radhakrishnan S; Narayanasamy A
    Int Ophthalmol; 2010 Aug; 30(4):429-34. PubMed ID: 20049507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of epiretinal membranes associated with Eales' disease: a clinicopathologic evaluation.
    Majji AB; Vemuganti GK; Shah VA; Singh S; Das T; Jalali S
    Eye (Lond); 2006 Jan; 20(1):46-54. PubMed ID: 15877102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic expression of leukemia inhibitory factor (LIF) blocks normal vascular development but not pathological neovascularization in the eye.
    Ash J; McLeod DS; Lutty GA
    Mol Vis; 2005 Apr; 11():298-308. PubMed ID: 15889014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
    Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
    Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Eales' Disease With Neovascular Glaucoma at First Presentation.
    Alfayyadh MA; Alabdulhadi HA; Almubarak MH
    Cureus; 2021 Sep; 13(9):e18302. PubMed ID: 34722077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
    Stalmans I
    Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eales' disease with central nervous system infarction.
    Katz B; Wheeler D; Weinreb RN; Swenson MR
    Ann Ophthalmol; 1991 Dec; 23(12):460-3. PubMed ID: 1785904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and activation of vascular endothelial cells in epiretinal membranes from patients with proliferative diabetic retinopathy. An immunohistochemistry and clinical study.
    Tang S; Le-Ruppert KC; Gabel VP
    Ger J Ophthalmol; 1994 May; 3(3):131-6. PubMed ID: 7518716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eales' disease: the great masquerader.
    Davis J; Schecter SH; Sowka J
    Optometry; 2009 Jul; 80(7):354-9. PubMed ID: 19545848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raised platelet thiobarbituric acid-reacting substances in proliferative Eales' disease.
    Srivastava P; Saxena S; Khanna VK; Kumar D; Nath R; Seth PK
    Indian J Ophthalmol; 2000 Dec; 48(4):307-9. PubMed ID: 11340890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic patients and retinal proliferation: an evaluation of the role of vascular endothelial growth factor (VEGF).
    Nicoletti VG; Nicoletti R; Ferrara N; Meli G; Reibaldi M; Reibaldi A
    Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):209-14. PubMed ID: 12845559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term follow-up of Eales' disease.
    Atmaca LS; Batioglu F; Atmaca Sonmez P
    Ocul Immunol Inflamm; 2002 Sep; 10(3):213-21. PubMed ID: 12789597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VEGF expression in dog retina after chorioretinal venous anastomosis].
    Lu N; Li Z; Sun X; Wang G; Zhang F; Peng X
    Zhonghua Yan Ke Za Zhi; 2002 Sep; 38(9):526-9. PubMed ID: 12410970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro.
    Hoffmann S; Friedrichs U; Eichler W; Rosenthal A; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):996-1002. PubMed ID: 12483322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New classification system-based visual outcome in Eales' disease.
    Saxena S; Kumar D
    Indian J Ophthalmol; 2007; 55(4):267-9. PubMed ID: 17595474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.